Oxidized Regenerated Cellulose Haemostat
- UID
- MFG/MD/2019/000187_aa06224a93603254ed27e23dc93903e5_2a941fc1d37fb478425b98cdfdc25224
- Device class
- Class D
- Brand name
- Surgi-ORC, HEMOCEL, ORCEL, PREMISUT, ORCBOND
- License holder
- Aegis Lifesciences Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- Oxidized Regenerated Cellulose Haemostat is designed to arrest capillary bleeding and bleeding from parenchymatous organs and resection areas at surgical interventions. It shall be used to stop bleeding when other haemostatic procedures are ineffective or impractical. It is suitable for use in general surgery and digestive surgery, neurosurgery (Surgi-ORC, HEMOCEL, ORCEL, PREMISUT, ORCBOND), plastic surgery, orthopaedic, gynaecology, urology, stomatology, traumatology, and many other branches of surgery. Oxidized Regenerated Cellulose Haemostat can be applied into cavities (Surgi-ORC, HEMOCEL, ORCEL, PREMISUT, ORCBOND) as well as endoscopic interventions or dental praxis
Oxidized Regenerated Cellulose Haemostat is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000187_aa06224a93603254ed27e23dc93903e5_2a941fc1d37fb478425b98cdfdc25224. This device is marketed under the brand name Surgi-ORC, HEMOCEL, ORCEL, PREMISUT, ORCBOND. The license holder is Aegis Lifesciences Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.